Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD

Clinical trial NCT03339973 · TERMINATED

Trial details

NCT number: NCT03339973
Sponsor: RHEACELL GmbH & Co. KG
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral Arterial Occlusive Disease

Start date: 2018-03-05
Primary completion: 2020-05-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.